In the present study, we demonstrated that the recombinant fusion protein Fv-LDP-D3 has high affinity for EGFR-overexpressing EC cells, ensuring localization to the tumor and reducing toxicity to normal cells. The gene discussed is EGFR; the disease is neoplasm.